Hamm, B <br/><br/>
Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.  [electronic resource] 

 -  Radiology  Jun 1995 
 - 785-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0033-8419 
<br/><br/><label>Standard No.: </label>10.1148/radiology.195.3.7754011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biliary Tract--anatomy & histology<br/>Contrast Media--adverse effects<br/>Double-Blind Method<br/>Gadolinium DTPA<br/>Humans<br/>Liver--anatomy & histology<br/>Magnetic Resonance Imaging<br/>Male<br/>Organometallic Compounds--adverse effects<br/>Pentetic Acid--adverse effects